Feld, J., Tremblay, D., Dougherty, M., Czaplinska, T., Sanchez, G., Brady, C., . . . Shih, A. H. (2021). Safety and Efficacy: Clinical Experience of Venetoclax in Combination With Hypomethylating Agents in Both Newly Diagnosed and Relapsed/Refractory Advanced Myeloid Malignancies. Hemasphere.
Citación estilo ChicagoFeld, Jonathan, et al. "Safety and Efficacy: Clinical Experience of Venetoclax in Combination With Hypomethylating Agents in Both Newly Diagnosed and Relapsed/Refractory Advanced Myeloid Malignancies." Hemasphere 2021.
Cita MLAFeld, Jonathan, et al. "Safety and Efficacy: Clinical Experience of Venetoclax in Combination With Hypomethylating Agents in Both Newly Diagnosed and Relapsed/Refractory Advanced Myeloid Malignancies." Hemasphere 2021.